EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients

Mohamed S. Othman, Ahmed M. Aref, Amal A. Mohamed, Wesam A. Ibrahim

ISRN Hepatology · 2013

DOI: 10.1155/2013/412317 ↗
AbstractBibliografische Angaben

Abstract

Interleukin-10 (IL-10) and interleukin-6 (IL-6) have been reported to be related to hepatocellular carcinoma (HCC) prognosis. This study aimed to investigate the clinical usefulness of serum levels of IL-6 and IL-10 as biomarkers for HCC among high-risk patients. Materials and Methods . 80 individuals were enrolled in this study; they were categorized into 4 groups: group 1 healthy individuals (NC) ( n = 20 ), group 2 chronic hepatitis C virus (HCV) patients ( n = 20 ), group 3 cirrhotic patients (LC) ( n = 20 ), and HCC group ( n = 20 ). Using ELISA technique serum levels of IL-6, IL-10, and alpha fetoprotein (AFP) were evaluated in all groups. Results . The mean serum levels of IL-6 were significantly higher in HCC than in LC, HCV, and NC groups ( 13.99 ± 1.80 , 7.49 ± 0.43 , 5.78 ± 0.74 , and 2.57 ± 0.31 ), respectively ( P < 0.05 ); also the serum levels of IL-10 were significantly higher in HCC compared with LC, HCV, and NC groups ( 13.69 ± 1.89 , 7.37 ± 0.53 , 5.18 ± 0.6 , and 3.31 ± 0.42 ) ( P < 0.05 ). We also found that the tumor size is correlated strongly with IL-6 and IL-10 levels ( r = 0.925 , P < 0.001 ; r = 0.821 , P < 0.001 ), respectively. Conclusion . The combination of those markers may help to identify a group of HCC patients with low AFP.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →